ArticleBMC cancer2025

Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors - a retrospective single center analysis.

Kilian Rhein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.